The estimated Net Worth of Andrew G Hinson is at least $1.84 Million dollars as of 16 August 2021. Mr. Hinson owns over 2,500 units of Biolife Solutions Inc stock worth over $409,883 and over the last 18 years he sold BLFS stock worth over $1,372,595. In addition, he makes $55,000 as Independent Director at Biolife Solutions Inc.
Sign up
Mr. Hinson BLFS stock SEC Form 4 insiders trading
Andrew has made over 18 trades of the Biolife Solutions Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he sold 2,500 units of BLFS stock worth $111,275 on 16 August 2021.
The largest trade he's ever made was exercising 21,428 units of Biolife Solutions Inc stock on 13 June 2018 worth over $28,499. On average, Andrew trades about 3,582 units every 50 days since 2007. As of 16 August 2021 he still owns at least 17,675 units of Biolife Solutions Inc stock.
You can see the complete history of Mr. Hinson stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Andrew Hinson biography
Andrew G. Hinson is an Independent Director of the Company. Mr. Hinson currently serves as a consultant to the biotechnology industry specializing in matters of clinical and regulatory affairs. Mr. Hinson served as Vice President of Clinical and Regulatory Affairs for LoneStar Heart, Inc. from 2004 to 2016. Mr. Hinson previously served as the Senior Director of research and clinical development at AnGes MG, Inc. (TSE: 4563) a biotechnology firm engaged in the development and commercialization of novel gene and cell therapies for the treatment of cardiovascular disease. Prior to that Mr. Hinson had a long career with Procter & Gamble Pharmaceutical (NYSE:PG) holding multiple technical and management positions in research, clinical development and medical affairs. Mr. Hinson has diverse experience in the cell and gene therapy markets and extensive experience with regulatory affairs and clinical development of new therapies for cardiac, neurologic, and gastrointestinal diseases. The Board has determined that Mr. Hinson should serve as a director because of his experience and knowledge of companies in the biotechnology space..
What is the salary of Andrew Hinson?
As the Independent Director of Biolife Solutions Inc, the total compensation of Andrew Hinson at Biolife Solutions Inc is $55,000. There are 11 executives at Biolife Solutions Inc getting paid more, with Michael Rice having the highest compensation of $2,241,770.
How old is Andrew Hinson?
Andrew Hinson is 55, he's been the Independent Director of Biolife Solutions Inc since 2007. There are 9 older and 8 younger executives at Biolife Solutions Inc. The oldest executive at Biolife Solutions Inc is Thomas Girschweiler, 61, who is the Director.
What's Andrew Hinson's mailing address?
Andrew's mailing address filed with the SEC is C/O BIOLIFE SOLUTIONS, INC., 3303 MONTE VILLA PARKWAY, SUITE 310, BOTHELL, WA, 98021.
Insiders trading at Biolife Solutions Inc
Over the last 21 years, insiders at Biolife Solutions Inc have traded over $156,215,880 worth of Biolife Solutions Inc stock and bought 12,236,637 units worth $91,960,074 . The most active insiders traders include Partners Master Fund, L.P.C..., Thomas Girschweiler, and Walter Villiger. On average, Biolife Solutions Inc executives and independent directors trade stock every 13 days with the average trade being worth of $1,018,157. The most recent stock trade was executed by Sarah Aebersold on 1 July 2024, trading 3,000 units of BLFS stock currently worth $63,090.
What does Biolife Solutions Inc do?
bothell, wa-based biolife solutions, inc. (nasdaq: blfs), is a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management app for smart shippers.
What does Biolife Solutions Inc's logo look like?
Complete history of Mr. Hinson stock trades at Biolife Solutions Inc
Biolife Solutions Inc executives and stock owners
Biolife Solutions Inc executives and other stock owners filed with the SEC include:
-
Michael Rice,
President, Chief Executive Officer, Director -
Aby Mathew,
Executive Vice President and Chief Scientific Officer -
Roderick de Greef,
Chief Financial Officer, Chief Operating Officer, Secretary, IR Contact Officer -
Michael P. Rice,
Chairman & CEO -
Dr. Aby J. Mathew,
Chairman of Scientific Advisory Board, Exec. VP & Chief Scientific Officer -
Roderick de Greef,
Pres & COO -
Karen Foster,
Chief Quality Officer -
Troy Wichterman,
Chief Financial Officer -
Todd Berard,
Chief Marketing Officer -
Raymond Cohen,
Independent Chairman of the Board -
Joseph Schick,
Independent Director -
Andrew Hinson,
Independent Director -
Thomas Girschweiler,
Director -
Karen Foster,
Chief Quality Officer -
Marcus Schulz,
Vice President, Global Sales -
Todd Berard,
Chief Marketing Officer -
Marcus Schulz,
Chief Revenue Officer -
Sarah Aebersold J.D.,
VP of Global HR -
Frederick Stewart,
Director -
Thomas Girschweiler,
Director -
Joe Annicchiarico,
Chief Operating Officer -
Daphne Taylor,
Chief Financial Officer -
Matt Snyder,
Vice President -
Walterwavi Holding Ag Villiger,
-
Partners Master Fund, L.P.C...,
-
Geraint Phillips,
SVP, Global Operations -
Timothy L. Moore,
Director -
Amy Du Ross,
Director -
Rachel Ellingson,
Director -
Walter Villiger,
10% owner -
John G Ph D Baust,
Director -
Howard S Breslow,
Director -
Alan F Rich,
Vice President -
Buskirk Robert Van,
Director -
James Mathers,
Chief Revenue Officer -
Dusty Tenney,
COO and President -
Joydeep Goswami,
Director -
Troy Wichterman,
Chief Financial Officer -
Sarah Aebersold,
Chief Human Resources Officer -
Garrie Richardson,
Chief Revenue Officer